MGNX MacroGenics, Inc.
Healthcare$4.47-1.32%ClosedMarket Cap: $284.1M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$6.00
Target (Median)
$6.00
Target Range
$6.00 - $6.00
Upside from current price: 34.2%
Rating Distribution
1 Strong Buy2 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-20 | Barclays | maintain | Overweight | Overweight |
| 2026-04-10 | B. Riley Securities | upgrade | Buy | Neutral |
| 2026-03-10 | Barclays | maintain | Overweight | Overweight |
| 2025-11-03 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2025-08-15 | Leerink Partners | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.53 | $94.3M | 4 |
| Sun Dec 31 | $-1.98 | $135.0M | 3 |
| Mon Dec 31 | $-1.74 | $177.6M | 1 |
| Tue Dec 31 | $-0.94 | $249.1M | 1 |